Research progresses of molecular mechanism of pyroptosis and its related diseases

Weihua Gong1, Ying Shi2, Jingjing Ren1

  • 1Clinical Laboratory, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Immunobiology
|December 12, 2019
PubMed

Insights

Pyroptosis, an inflammatory programmed cell death, involves Caspase-1/11 and Gasdermin proteins forming cell membrane pores. This cell death pathway is linked to various diseases, making its mechanisms crucial for study.

Area of Science:

  • Cell Biology
  • Immunology
  • Molecular Biology

Background:

  • Pyroptosis is a recently identified form of programmed cell death characterized by inflammatory responses.
  • It is critically regulated by Caspase-1 (classic pathway) and Caspase-11 in mice (non-canonical pathway), or Caspase-4/-5 in humans.
  • The Gasdermin protein family plays a central role in mediating pyroptosis.

Purpose of the Study:

  • To review the molecular mechanisms underlying pyroptosis.
  • To discuss the association between pyroptosis and the pathogenesis of various diseases.

Main Methods:

  • Literature review of scientific publications on pyroptosis.
  • Analysis of molecular pathways involving caspases and Gasdermin.
  • Examination of disease relevance and clinical implications.

Main Results:

  • Cleavage of Gasdermin by inflammatory caspases releases a pore-forming N-terminal fragment.
  • This fragment induces membrane permeabilization, triggering pyroptotic cell death.
  • Pyroptosis is implicated in the development and progression of several diseases.

Conclusions:

  • Pyroptosis is a caspase-dependent inflammatory cell death process mediated by Gasdermin.
  • Understanding pyroptosis mechanisms is essential for elucidating its role in disease.
  • Further research into pyroptosis may offer therapeutic targets for related diseases.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.2K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.1K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K